BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

311 related articles for article (PubMed ID: 34890089)

  • 1. hsa_circ_0003410 promotes hepatocellular carcinoma progression by increasing the ratio of M2/M1 macrophages through the miR-139-3p/CCL5 axis.
    Cao P; Ma B; Sun D; Zhang W; Qiu J; Qin L; Xue X
    Cancer Sci; 2022 Feb; 113(2):634-647. PubMed ID: 34890089
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Silencing of hsa_circ_0101145 reverses the epithelial-mesenchymal transition in hepatocellular carcinoma via regulation of the miR-548c-3p/LAMC2 axis.
    Jin J; Liu H; Jin M; Li W; Xu H; Wei F
    Aging (Albany NY); 2020 Jun; 12(12):11623-11635. PubMed ID: 32554866
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CircRNA hsa_circ_0110102 inhibited macrophage activation and hepatocellular carcinoma progression via miR-580-5p/PPARĪ±/CCL2 pathway.
    Wang X; Sheng W; Xu T; Xu J; Gao R; Zhang Z
    Aging (Albany NY); 2021 Apr; 13(8):11969-11987. PubMed ID: 33891564
    [TBL] [Abstract][Full Text] [Related]  

  • 4. circRNA hsa_circ_104566 Sponged miR-338-3p to Promote Hepatocellular Carcinoma Progression.
    Liu G; Guo W; Rao M; Qin J; Hu F; Li K
    Cell Transplant; 2020; 29():963689720963948. PubMed ID: 33028110
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Circular RNA hsa_circ_0005397 promotes hepatocellular carcinoma progression by regulating the miR-326/PDK2 axis.
    Gong J; Du C; Sun N; Xiao X; Wu H
    J Gene Med; 2021 Jun; 23(6):e3332. PubMed ID: 33783904
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Exosomal hsa_circ_0004658 derived from RBPJ overexpressed-macrophages inhibits hepatocellular carcinoma progression via miR-499b-5p/JAM3.
    Zhang L; Zhang J; Li P; Li T; Zhou Z; Wu H
    Cell Death Dis; 2022 Jan; 13(1):32. PubMed ID: 35013102
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Downregulation of hsa_circ_0074854 Suppresses the Migration and Invasion in Hepatocellular Carcinoma via Interacting with HuR and via Suppressing Exosomes-Mediated Macrophage M2 Polarization.
    Wang Y; Gao R; Li J; Tang S; Li S; Tong Q; Li S
    Int J Nanomedicine; 2021; 16():2803-2818. PubMed ID: 33880025
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hsa_circ_0101432 promotes the development of hepatocellular carcinoma (HCC) by adsorbing miR-1258 and miR-622.
    Zou H; Xu X; Luo L; Zhang Y; Luo L; Yao Y; Xiang G; Huang X; Wang G
    Cell Cycle; 2019 Oct; 18(19):2398-2413. PubMed ID: 31095447
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Has_circ_0008583 modulates hepatocellular carcinoma progression through the miR-1301-3p/METTL3 pathway.
    Wang F; Xie Z; Zhang N; Ding H; Xiong K; Guo L; Huang H; Wen Z
    Bioengineered; 2022 Jan; 13(1):1185-1197. PubMed ID: 35258395
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hsa_circ_0003998 promotes epithelial to mesenchymal transition of hepatocellular carcinoma by sponging miR-143-3p and PCBP1.
    Song LN; Qiao GL; Yu J; Yang CM; Chen Y; Deng ZF; Song LH; Ma LJ; Yan HL
    J Exp Clin Cancer Res; 2020 Jun; 39(1):114. PubMed ID: 32552766
    [TBL] [Abstract][Full Text] [Related]  

  • 11. hsa_circ_0006916 promotes hepatocellular carcinoma progression by activating the miR-337-3p/STAT3 axis.
    Zhou XY; Yang H; Bai YQ; Li XL; Han SY; Zhou BX
    Cell Mol Biol Lett; 2020 Nov; 25(1):47. PubMed ID: 33292166
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hsa_circ_0079875 functions as a competitive endogenous RNA to promote hepatocellular carcinoma progression.
    Liu Y; Luo X; Chen W; Dong Z; Cheng T; Chen L; Ju L; Cai W; Bian Z
    Cell Cycle; 2024 Mar; 23(5):519-536. PubMed ID: 38684479
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Circular RNA hsa_circ_103809 suppresses hepatocellular carcinoma proliferation and invasion by sponging miR-620.
    Li X; Shen M
    Eur Rev Med Pharmacol Sci; 2019 Feb; 23(2):555-566. PubMed ID: 30720163
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Circular RNA hsa_circ_0000673 promotes hepatocellular carcinoma malignance by decreasing miR-767-3p targeting SET.
    Jiang W; Wen D; Gong L; Wang Y; Liu Z; Yin F
    Biochem Biophys Res Commun; 2018 Jun; 500(2):211-216. PubMed ID: 29627570
    [TBL] [Abstract][Full Text] [Related]  

  • 15. hsa_circ_0000092 promotes hepatocellular carcinoma progression through up-regulating HN1 expression by binding to microRNA-338-3p.
    Pu J; Wang J; Li W; Lu Y; Wu X; Long X; Luo C; Wei H
    J Cell Mol Med; 2024 Mar; 28(6):e15010. PubMed ID: 32077624
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oncogenic hsa_circ_0091581 promotes the malignancy of HCC cell through blocking miR-526b from degrading c-MYC mRNA.
    Wei X; Zheng W; Tian P; He Y; Liu H; Peng M; Li X; Liu X
    Cell Cycle; 2020 Apr; 19(7):817-824. PubMed ID: 32116112
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of hsa_circ_0000711 expression level on proliferation and apoptosis of hepatoma cells.
    Chen KH; Pan JF; Chen ZX; Pan D; Gao T; Huang M; Huang JN
    Eur Rev Med Pharmacol Sci; 2020 Apr; 24(8):4161-4171. PubMed ID: 32373952
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Circular RNA hsa_circ_0005239 contributes to hepatocellular carcinoma cell migration, invasion, and angiogenesis by targeting the miR-34a-5p/PD-L1 axis.
    He T; Huang J; Liang H; Zhong B; Xu G; Zhu X
    Cell Biol Int; 2023 Sep; 47(9):1519-1534. PubMed ID: 37208963
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Circular RNA hsa_circ_0051040 Promotes Hepatocellular Carcinoma Progression by Sponging miR-569 and Regulating ITGAV Expression.
    Ju L; Yao M; Lu R; Cao Y; Wang H; Yuan L; Xiao F; Shao J; Cai W; Chen L; Bian Z
    Cells; 2022 Nov; 11(22):. PubMed ID: 36429000
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Circular RNA hsa_circ_0056836 functions an oncogenic gene in hepatocellular carcinoma through modulating miR-766-3p/FOSL2 axis.
    Li Z; Liu Y; Yan J; Zeng Q; Hu Y; Wang H; Li H; Li J; Yu Z
    Aging (Albany NY); 2020 Feb; 12(3):2485-2497. PubMed ID: 32048611
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.